Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RN7SK pseudogene 68 (RN7SKP68) is a noncoding RNA pseudogene, meaning it is a genomic sequence similar to the functional 7SK small nuclear RNA (7SK snRNA) but is not believed to be transcribed or functional. The functional 7SK snRNA is an abundant small nuclear RNA that plays a major regulatory role in transcription by sequestering and inhibiting the positive transcription elongation factor b (P-TEFb), thus modulating the activity of RNA polymerase II and thereby gene expression[1][2][3]. Unlike 7SK snRNA, which has well-documented cellular roles and disease associations, RN7SKP68 as a pseudogene lacks evidence of biological function, protein product, or clinical relevance. NOTES ON ACCURACY AND CONTEXT - The entry refers to a pseudogene, not the functional small nuclear RNA (7SK snRNA). Pseudogenes are generally nonfunctional remnants of genes, often not transcribed or translated, and are not recognized as molecular targets in any therapeutic or biomarker context[3]. - The functional 7SK snRNA is involved in the regulation of transcription, chromatin architecture, and is associated with diseases when dysregulated (such as cancer and heart disease)[2]. However, these functions do not apply to the pseudogene RN7SKP68. - RN7SKP68 does not belong to any common molecular family like “receptor,” “enzyme,” or “transcription factor”; it is classified simply as a pseudogene. - There are hundreds of RN7SK pseudogenes annotated in the human genome, but only a single bona fide 7SK snRNA locus that is transcribed and functional[3]. Key Information for Structured Extraction - RN7SKP68 is not a canonical molecular target and should not be included as a therapeutic target or active biomarker. - No known aliases apart from formal naming conventions (pseudogene numbers may vary between databases). - Structured data on mechanism, disease roles, or related drugs is not applicable to this pseudogene. In summary: RN7SK pseudogene 68 is an inactive, noncoding RNA pseudogene and is not considered a drug target, disease gene, or biomarker; its listing here is likely due to automatic annotation rather than biological or clinical interest, and it should be flagged as incorrect if used as a molecular target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RN7SK pseudogene 68 (RN7SKP68).